Accuray Incorporated (NASDAQ:ARAY) Stock Position Increased by Hsbc Holdings PLC

Hsbc Holdings PLC raised its position in Accuray Incorporated (NASDAQ:ARAY) by 55.1% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 101,683 shares of the medical equipment provider’s stock after purchasing an additional 36,108 shares during the quarter. Hsbc Holdings PLC owned about 0.10% of Accuray worth $180,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently made changes to their positions in the business. Renaissance Technologies LLC grew its holdings in Accuray by 0.3% in the 2nd quarter. Renaissance Technologies LLC now owns 2,812,184 shares of the medical equipment provider’s stock worth $5,118,000 after buying an additional 7,500 shares in the last quarter. Perritt Capital Management Inc increased its holdings in shares of Accuray by 139.3% during the second quarter. Perritt Capital Management Inc now owns 120,000 shares of the medical equipment provider’s stock valued at $218,000 after purchasing an additional 69,864 shares during the period. Allspring Global Investments Holdings LLC raised its stake in shares of Accuray by 6,480.3% during the second quarter. Allspring Global Investments Holdings LLC now owns 35,007 shares of the medical equipment provider’s stock valued at $64,000 after purchasing an additional 34,475 shares in the last quarter. Bank of New York Mellon Corp lifted its holdings in Accuray by 3.3% in the second quarter. Bank of New York Mellon Corp now owns 279,426 shares of the medical equipment provider’s stock worth $509,000 after purchasing an additional 8,864 shares during the period. Finally, Nisa Investment Advisors LLC grew its position in Accuray by 253,483.3% in the 2nd quarter. Nisa Investment Advisors LLC now owns 15,215 shares of the medical equipment provider’s stock valued at $28,000 after buying an additional 15,209 shares in the last quarter. Institutional investors own 64.08% of the company’s stock.

Accuray Stock Up 7.9 %

ARAY stock opened at $1.91 on Friday. Accuray Incorporated has a 52 week low of $1.40 and a 52 week high of $3.10. The company has a current ratio of 1.66, a quick ratio of 0.95 and a debt-to-equity ratio of 3.65. The company has a market capitalization of $189.56 million, a price-to-earnings ratio of -8.68 and a beta of 1.39. The firm’s 50-day moving average is $1.92 and its two-hundred day moving average is $1.93.

Accuray (NASDAQ:ARAY) last issued its quarterly earnings results on Wednesday, August 14th. The medical equipment provider reported $0.03 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.03. Accuray had a negative return on equity of 33.65% and a negative net margin of 3.48%. The company had revenue of $134.29 million for the quarter, compared to analysts’ expectations of $122.80 million. During the same period last year, the firm earned ($0.03) EPS. On average, analysts forecast that Accuray Incorporated will post -0.01 earnings per share for the current fiscal year.

About Accuray

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate.